ANTI Stock Price, Chart, Stats & News

Antigenics, Inc.
Save
Antigenics, Inc. (ANTI) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
ANTI chart
About
Health care
Sector
Biotechnology
Industry
Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer.
Similar securities
Based on sector and market capitalization
Report issue





